Takeda-backed Ascentage Pharma Sets Terms for $170M IPO

Seeking AlphaJan 21 18:30 ET

Community-Driven, Sustainable Development Project at 585 Kendall Reaches Major Construction Milestone

BusinesswireJan 21 15:27 ET

Keros Spikes as Teva Deal Takes Effect; Cantor Downgrades on Trial Setback

Seeking AlphaJan 21 12:12 ET

Keros to Receive $200 Million From Takeda In Connection to Elritercept License Deal

MT NewswiresJan 21 09:15 ET

Express News | Keros Therapeutics Global License Agreement With Takeda To Advance Elritercept Became Effective Jan. 16, Triggering $200M Payment From Takeda To Keros

BenzingaJan 21 08:11 ET

Takeda Canada Says Health Canada Granted Market Authorization for Fruzaqla

MT NewswiresJan 21 04:40 ET